0 likes | 12 Views
The hormone replacement therapy market is segmented by product into estrogen replacement therapy, human growth hormone replacement therapy, thyroid replacement therapy, and testosterone replacement therapy; by route of administration into oral, parenteral and transdermal; by type of disease into menopause, hypothyroidism, male hypothyroidism, growth hormone deficiency, cancer & others. The hormone replacement therapy market is anticipated to record a CAGR of around 8% during the forecast period i.e. 2023-2033.
E N D